4.5 Article

Differences between physicians' and nurse practitioners' viewpoints on reasons for clozapine underprescription

Journal

BRAIN AND BEHAVIOR
Volume 9, Issue 7, Pages -

Publisher

WILEY
DOI: 10.1002/brb3.1318

Keywords

antipsychotic agents; clozapine; nurse practitioners; physician's practice patterns; schizophrenia spectrum and other psychotic disorders

Ask authors/readers for more resources

Introduction Clozapine (CLZ) is the only proven effective therapy for treatment-resistant schizophrenia, but it is underutilized across the globe. Previous findings suggest a lack of experience with CLZ prescription and concerns about CLZ's pharmacological characteristics are the prime reasons for CLZ underutilization. To our knowledge, it is currently unknown whether the reasons for underutilization and suggested solutions differ between physicians and nurse practitioners. Such differences are important as nurse practitioners are becoming increasingly involved in prescribing CLZ. Methods To examine to what degree physicians and nurse practitioners differ with regard to their take on reasons for CLZ underutilization and suggested solutions, an online questionnaire was distributed to physicians and nurse practitioners. The primary outcome was to compare the patient-related and prescriber-related reasons for CLZ underprescription between physicians and nurse practitioners, while secondary outcome measures included the potential solutions to prevent this underprescription. Results Physicians (N = 112) and nurse practitioners (N = 41) agreed that the two most common reasons for underprescription (patient-related and prescriber-related) were refusal to undergo regular blood tests and side-effect concerns. They also agreed that the third most common prescriber-related reason was medical complications. Physicians rated patients' unwillingness to switch medication as the third most common reason for CLZ underprescription, whereas nurse practitioners rated refusal to undergo baseline bloodtests as the third most common reason. The solutions to reduce underprescription largely corresponded between both groups. Conclusions We conclude that slight differences exist between physicians' and nurse practitioners' viewpoints on patient-related and prescriber-related reasons for CLZ underprescription. Future research projects should involve patients to elucidate whether the patient-related factors put forward by prescribers align with the patients' opinions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Neurosciences

Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors

Niamh Mullins, JooEun Kang, Adrian Campos, Jonathan R. Coleman, Alexis C. Edwards, Hanga Galfalvy, Daniel F. Levey, Adriana Lori, Andrey Shabalin, Anna Starnawska, Mei-Hsin Su, Hunna J. Watson, Mark Adams, Swapnil Awasthi, Michael Ganda, Jonathan D. Hafferty, Akitoyo Hishimoto, Minsoo Kim, Satoshi Okazaki, Ikuo Otsuka, Stephan Ripke, Erin B. Ware, Andrew W. Bergen, Wade H. Berrettini, Martin Bohus, Harry Brandt, Xiao Chang, Wei J. Chen, Hsi-Chung Chen, Steven Crawford, Scott Crow, Emily DiBlasi, Philibert Duriez, Fernando Fernandez-Aranda, Manfred M. Fichter, Steven Gallinger, Stephen J. Glatt, Philip Gorwood, Yiran Guo, Hakon Hakonarson, Katherine A. Halmi, Hai-Gwo Hwu, Sonia Jain, Stephane Jamain, Susana Jimenez-Murcia, Craig Johnson, Allan S. Kaplan, Walter H. Kaye, Pamela K. Keel, James L. Kennedy, Kelly L. Klump, Dong Li, Shih-Cheng Liao, Klaus Lieb, Lisa Lilenfeld, Chih-Min Liu, Pierre J. Magistretti, Christian R. Marshall, James E. Mitchell, Eric T. Monson, Richard M. Myers, Dalila Pinto, Abigail Powers, Nicolas Ramoz, Stefan Roepke, Vsevolod Rozanov, Stephen W. Scherer, Christian Schmahl, Marcus Sokolowski, Michael Strober, Laura M. Thornton, Janet Treasure, Ming T. Tsuang, Stephanie H. Witt, D. Blake Woodside, Zeynep Yilmaz, Lea Zillich, Rolf Adolfsson, Ingrid Agartz, Tracy M. Air, Martin Alda, Lars Alfredsson, Ole A. Andreassen, Adebayo Anjorin, Vivek Appadurai, Maria Soler Artigas, Sandra Van der Auwera, M. Helena Azevedo, Nicholas Bass, Claiton H. D. Bau, Bernhard T. Baune, Frank Bellivier, Klaus Berger, Joanna M. Biernacka, Tim B. Bigdeli, Elisabeth B. Binder, Michael Boehnke, Marco P. Boks, Rosa Bosch, David L. Braff, Richard Bryant, Monika Budde, Enda M. Byrne, Wiepke Cahn, Miguel Casas, Enrique Castelao, Jorge A. Cervilla, Boris Chaumette, Sven Cichon, Aiden Corvin, Nicholas Craddock, David Craig, Franziska Degenhardt, Srdjan Djurovic, Howard J. Edenberg, Ayman H. Fanous, Jerome C. Foo, Andreas J. Forstner, Mark Frye, Janice M. Fullerton, Justine M. Gatt, Pablo Gejman, Ina Giegling, Hans J. Grabe, Melissa J. Green, Eugenio H. Grevet, Maria Grigoroiu-Serbanescu, Blanca Gutierrez, Jose Guzman-Parra, Steven P. Hamilton, Marian L. Hamshere, Annette Hartmann, Joanna Hauser, Stefanie Heilmann-Heimbach, Per Hoffmann, Marcus Ising, Ian Jones, Lisa A. Jones, Lina Jonsson, Rene S. Kahn, John R. Kelsoe, Kenneth S. Kendler, Stefan Kloiber, Karestan C. Koenen, Manolis Kogevinas, Bettina Konte, Marie-Odile Krebs, Mikael Lander, Jacob Lawrence, Marion Leboyer, Phil H. Lee, Douglas F. Levinson, Calwing Liao, Jolanta Lissowska, Susanne Lucae, Fermin Mayoral, Susan L. McElroy, Patrick McGrath, Peter McGuffin, Andrew McQuillin, Sarah E. Medland, Divya Mehta, Ingrid Melle, Yuri Milaneschi, Philip B. Mitchell, Esther Molina, Gunnar Morken, Preben Bo Mortensen, Bertram Mueller-Myhsok, Caroline Nievergelt, Vishwajit Nimgaonkar, Markus M. Noethen, Michael C. O'Donovan, Roel A. Ophoff, Michael J. Owen, Carlos Pato, Michele T. Pato, Brenda W. J. H. Penninx, Jonathan Pimm, Giorgio Pistis, James B. Potash, Robert A. Power, Martin Preisig, Digby Quested, Josep Antoni Ramos-Quiroga, Andreas Reif, Marta Ribases, Vanesa Richarte, Marcella Rietschel, Margarita Rivera, Andrea Roberts, Gloria Roberts, Guy A. Rouleau, Diego L. Rovaris, Dan Rujescu, Cristina Sanchez-Mora, Alan R. Sanders, Peter R. Schofield, Thomas G. Schulze, Laura J. Scott, Alessandro Serretti, Jianxin Shi, Stanley Shyn, Lea Sirignano, Pamela Sklar, Olav B. Smeland, Jordan W. Smoller, Edmund J. S. Sonuga-Barke, Gianfranco Spalletta, John S. Strauss, Beata Swiatkowska, Maciej Trzaskowski, Gustavo Turecki, Laura Vilar-Ribo, John B. Vincent, Henry Voelzke, James T. R. Walters, Cynthia Shannon Weickert, Thomas W. Weickert, Myrna M. Weissman, Leanne M. Williams, Naomi R. Wray, Clement C. Zai, Allison E. Ashley-Koch, Jean C. Beckham, Elizabeth R. Hauser, Michael A. Hauser, Nathan A. Kimbrel, Jennifer H. Lindquist, Benjamin McMahon, David W. Oslin, Xuejun Qin, Esben Agerbo, Anders D. Borglum, Gerome Breen, Annette Erlangsen, Tonu Esko, Joel Gelernter, David M. Hougaard, Ronald C. Kessler, Henry R. Kranzler, Qingqin S. Li, Nicholas G. Martin, Andrew M. McIntosh, Ole Mors, Merete Nordentoft, Catherine M. Olsen, David Porteous, Robert J. Ursano, Danuta Wasserman, Thomas Werge, David C. Whiteman, Cynthia M. Bulik, Hilary Coon, Ditte Demontis, Anna R. Docherty, Po-Hsiu Kuo, Cathryn M. Lewis, J. John Mann, Miguel E. Renteria, Daniel J. Smith, Eli A. Stahl, Murray B. Stein, Fabian Streit, Virginia Willour, Douglas M. Ruderfer

Summary: A genome-wide association study identified significant genetic loci associated with suicide attempts, particularly one locus on chromosome 7 which is implicated in risk-taking behavior, smoking, and insomnia. The study also revealed strong genetic correlations between suicide attempts and psychiatric disorders, as well as other nonpsychiatric traits like smoking, pain, and lower socioeconomic status. Conditioning on psychiatric disorders reduced the genetic correlations between suicide attempts and psychiatric disorders, indicating a shared biology with nonpsychiatric risk factors.

BIOLOGICAL PSYCHIATRY (2022)

Article Clinical Neurology

Examining facial emotion recognition as an intermediate phenotype for psychosis: Findings from the EUGEI study

Laura Fusar-Poli, Lotta-Katrin Pries, Jim van Os, Gamze Erzin, Philippe Delespaul, Gunter Kenis, Juryen J. Luykx, Bochao D. Lin, Alexander L. Richards, Berna Akdede, Tolga Binbay, Vesile Altinyazar, Berna Yalincetin, Guvem Gumus-Akay, Burgin Cihan, Haldun Soygur, Halis Ulas, Eylem Sahin Cankurtaran, Semra Ulusoy Kaymak, Marina M. Mihaljevic, Sanja Andric-Petrovic, Tijana Mirjanic, Miguel Bernardo, Gisela Mezquida, Silvia Amoretti, Julio Bobes, Pilar A. Saiz, Maria Paz Garcia-Portilla, Julio Sanjuan, Eduardo J. Aguilar, Jose Luis Santos, Estela Jimenez-Lopez, Manuel Arrojo, Angel Carracedo, Gonzalo Lopez, Javier Gonzalez-Penas, Mara Parellada, Nadja P. Maric, Cem Atbasoglu, Alp Ucok, Koksal Alptekin, Meram Can Saka, Eugenio Aguglia, Celso Arango, Michael O'Donovan, Bart P. F. Rutten, Sinan Guloksuz

Summary: The study found that facial emotion recognition deficits may serve as an intermediate phenotype for schizophrenia using a proxy genetic risk approach. However, no significant association was observed between facial emotion recognition and polygenic risk score for schizophrenia. Further research should investigate the genetic mechanisms underlying facial emotion recognition phenotypes trans-diagnostically.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2022)

Article Psychology, Clinical

Psychological trauma and the genetic overlap between posttraumatic stress disorder and major depressive disorder

Jessica Mundy, Christopher Hubel, Joel Gelernter, Daniel Levey, Robin M. Murray, Megan Skelton, Murray B. Stein, Evangelos Vassos, Gerome Breen, Jonathan R. Coleman

Summary: The study found that there is a genetic basis for trauma sensitivity, with shared genetic components between PTSD and MDD. Furthermore, there was a higher genetic correlation between PTSD and recurrent MDD in individuals reporting trauma, and those with recurrent MDD were more likely to report trauma exposure.

PSYCHOLOGICAL MEDICINE (2022)

Article Psychology, Clinical

Independent contribution of polygenic risk for schizophrenia and cannabis use in predicting psychotic-like experiences in young adulthood: testing gene x environment moderation and mediation

Laurent Elkrief, Bochao Lin, Mattia Marchi, Mohammad H. Afzali, Tobias Banaschewski, Arun L. W. Bokde, Erin Burke Quinlan, Sylvane Desrivieres, Herta Flor, Hugh Garavan, Penny Gowland, Andreas Heinz, Bernd Ittermann, Jean-Luc Martinot, Marie-Laure Paillere Martinot, Frauke Nees, Dimitri Papadopoulos Orfanos, Tomas Paus, Luise Poustka, Sarah Hohmann, Juliane H. Froehner, Michael N. Smolka, Henrik Walter, Robert Whelan, Gunter Schumann, Jurjen Luykx, Marco P. Boks, Patricia J. Conrod

Summary: This study examines the relationship between cannabis use, genetic risk for schizophrenia, and psychotic-like experiences. The results suggest that cannabis use remains a risk factor for psychotic-like experiences, above and beyond genetic vulnerability for schizophrenia.

PSYCHOLOGICAL MEDICINE (2023)

Article Psychology, Clinical

Longitudinal associations between alcohol use, smoking, genetic risk scoring and symptoms of depression in the general population: a prospective 6-year cohort study

N. de Boer, J. Vermeulen, B. Lin, J. van Os, M. ten Have, R. de Graaf, S. van Dorsselaer, M. Bak, B. Rutten, A. Batalla, S. Guloksuz, J. J. Luykx

Summary: This study aimed to examine the relationships between smoking, alcohol use, and mood disorders. The results showed that smoking and the number of cigarettes per day were positively associated with depressive symptoms, while moderate alcohol consumption was associated with a reduction in symptoms. Longitudinally, reductions in smoking behavior and alcohol consumption were associated with improvements in depressive symptoms.

PSYCHOLOGICAL MEDICINE (2023)

Article Psychology, Clinical

Context v. algorithm: evidence that a transdiagnostic framework of contextual clinical characterization is of more clinical value than categorical diagnosis

Jim van Os, Lotta-Katrin Pries, Margreet ten Have, Ron de Graaf, Saskia van Dorsselaer, Maarten Bak, Gunter Kenis, Bochao D. Lin, Nicole Gunther, Jurjen J. Luykx, Bart P. F. Rutten, Sinan Guloksuz

Summary: Background: Combining the contextual clinical characterization framework with categorical algorithm-based diagnosis can provide more clinical value to patients. Methods: Prospective analysis of data from multiple domains to predict the impact on care needs and healthcare outcomes. Results: The predictive power of the contextual clinical characterization components in joint models exceeded that of any individual component, and the polygenic risk scores did not contribute significantly to the models. Conclusion: The transdiagnostic framework of contextual clinical characterization is more valuable to patients than a categorical system of algorithmic ordering of psychopathology.

PSYCHOLOGICAL MEDICINE (2023)

Article Clinical Neurology

Stratified psychiatry: Tomorrow's precision psychiatry?

Martijn Arns, Hanneke van Dijk, Jurjen J. Luykx, Guido van Wingen, Sebastian Olbrich

Summary: The shift from one-size-fits-all psychiatry to personalized psychiatry emphasizes the importance of precision and stratified psychiatry, utilizing biomarkers to better guide patients to receive optimal treatment.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2022)

Article Psychiatry

Selective outcome reporting across psychopharmacotherapy randomized controlled trials

Michelle Lancee, Marleen Schuring, Joeri K. Tijdink, An-Wen Chan, Christiaan H. Vinkers, Jurjen J. Luykx

Summary: The study found discrepancies between trial registrations and publications in research investigating medication for depressive, bipolar, and psychotic disorders, especially in non-industry funded trials.

INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH (2022)

Article Biochemistry & Molecular Biology

Comprehensive analyses of RNA-seq and genome-wide data point to enrichment of neuronal cell type subsets in neuropsychiatric disorders

M. Olislagers, K. Rademaker, R. A. H. Adan, B. D. Lin, J. J. Luykx

Summary: The study provides comprehensive evidence for a subset of neuronal cell types being consistently implicated in several, but not all psychiatric disorders, while non-neuronal cell types seem less implicated.

MOLECULAR PSYCHIATRY (2022)

Article Psychology, Clinical

Polygenic risk, familial liability and stress reactivity in psychosis: an experience sampling study

Anita Schick, Ruud van Winkel, Bochao D. Lin, Jurjen J. Luykx, Sonja M. C. de Zwarte, Kristel R. van Eijk, Group Investigators, Inez Myin-Germeys, Ulrich Reininghaus

Summary: This study aimed to investigate the impact of polygenic risk on stress reactivity in individuals with psychosis, their relatives, and controls. The results showed that polygenic risk score modified the associations between momentary stress and psychotic experiences, suggesting that it may amplify reactivity to stress in unaffected individuals but attenuate stress reactivity in relatives. These findings suggest that polygenic risk operates differently than previously assumed.

PSYCHOLOGICAL MEDICINE (2023)

Article Psychiatry

Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials

Heidi Taipale, Johannes Schneider-Thoma, Justo Pinzon-Espinosa, Joaquim Radua, Orestis Efthimiou, Christiaan H. Vinkers, Ellenor Mittendorfer-Rutz, Narcis Cardoner, Luis Pintor, Antti Tanskanen, Anneka Tomlinson, Paolo Fusar-Poli, Andrea Cipriani, Eduard Vieta, Stefan Leucht, Jari Tiihonen, Jurjen J. Luykx

Summary: Most evidence about the efficacy and safety of antipsychotics in schizophrenia spectrum disorders comes from randomized clinical trials (RCTs), which only represent a small portion of real-world patients. This study quantified the proportion of ineligible patients with schizophrenia spectrum disorders for RCTs and explored the differences in clinical outcomes between eligible and ineligible individuals. The findings showed that underrepresented patients had slightly higher risks of admission due to psychosis while receiving maintenance treatment than RCT-eligible patients.

JAMA PSYCHIATRY (2022)

Article Psychiatry

Age- and sex-specific associations between risk scores for schizophrenia and self-reported health in the general population

Vincent Paquin, Lotta-Katrin Pries, Margreet ten Have, Maarten Bak, Nicole Gunther, Ron de Graaf, Saskia van Dorsselaer, Bochao D. Lin, Kristel R. van Eijk, Gunter Kenis, Alexander Richards, Michael C. O'Donovan, Jurjen J. Luykx, Bart P. F. Rutten, Jim van Os, Jai L. Shah, Sinan Guloksuz

Summary: The health correlates of polygenic risk and exposome scores for schizophrenia may vary depending on age and sex. This study found that there were larger associations between higher exposome scores and poorer health among female and older individuals.

SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY (2023)

Article Psychiatry

Clustering Schizophrenia Genes by Their Temporal Expression Patterns Aids Functional Interpretation

Dennis van der Meer, Weiqiu Cheng, Jaroslav Rokicki, Sara Fernandez-Cabello, Alexey Shadrin, Olav B. Smeland, Friederike Ehrhart, Sinan Guloksuz, Lotta-Katrin Pries, Bochao Lin, Bart P. F. Rutten, Jim van Os, Michael O'Donovan, Alexander L. Richards, Nils Eiel Steen, Srdjan Djurovic, Lars T. Westlye, Ole A. Andreassen, Tobias Kaufmann

Summary: This study found that schizophrenia is shaped by disruptions of separate biological processes at different stages of brain development. The interaction of genetic risk factors, influenced by their timing of expression, helps in better understanding the development of schizophrenia.

SCHIZOPHRENIA BULLETIN (2023)

Letter Psychiatry

The performance of ChatGPT in generating answers to clinical questions in psychiatry: a two-layer assessment

Jurjen J. Luykx, Frank Gerritse, Philippe C. Habets, Christiaan H. Vinkers

WORLD PSYCHIATRY (2023)

Article Neurosciences

Associations between psychotropic drugs and rsEEG connectivity and network characteristics: a cross-sectional study in hospital-admitted psychiatric patients

Melissa G. Zandstra, Hannah Meijs, Metten Somers, Cornelis J. Stam, Bieke de Wilde, Jan van Hecke, Peter Niemegeers, Jurjen J. Luykx, Edwin van Dellen

Summary: This study aimed to investigate the impact of single and multi-class psychotropic treatments on resting-state EEG characteristics in a psychiatric population. The results showed significant associations between the use of antidepressants, antipsychotics, and benzodiazepines and rsEEG functional connectivity and network topology. The study highlighted the importance of considering specific psychotropics and their interactions when studying rsEEG biomarkers in medicated psychiatric patients.

FRONTIERS IN NEUROSCIENCE (2023)

No Data Available